PAR 4.84% 29.5¢ paradigm biopharmaceuticals limited..

experience, page-4

  1. 756 Posts.
    lightbulb Created with Sketch. 139
    That changes nothing. You can't convince the unconvinceable regardless of what evidence you post in here. Peer reviewed research is the only evidence that we can use and this is still a little limited at the moment. Also we can use ASX announcements by PAR which we have no choice but to assume are accurate and honest.
    Posting pre- and post- MRI's doesn't indicate that the person has more/less pain or increased/decreased ROM, etc. Many people on here wont even be able to read an MRI scan or even know if it is from the same patient.
    I can access thousands of x-rays, CT scans and MRI's on the Radiology company websites here in WA (and I can even post x-rays taken at our clinic) and post in here and I can be completely disingenuous with the analysis of the scans and 99% of posters in here with be "none the wiser".
    This company still has a medium to high risk profile and obviously with time, the risk profile will diminish as milestones are hopefully ticked off successfully.
    The rewards are massive if PAR can pull it off, but seriously, it's probably less than a 50:50 chance in my opinion. Phase III's are tough and we are definitely not being given all the info by PAR management and the researchers. I have referred 3 patients now and the wait list for the WA specialist is currently full, therefore not taking any more referrals.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $86.19K 286.7K

Buyers (Bids)

No. Vol. Price($)
4 70151 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 18600 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.